5/3/2019 11:32 AM
H.C. Wainwright just initiated coverage on the drugmaker Collegium Pharmaceutical, Inc (NASDAQ:COLL) with a "buy" rating and a $23 price target -- a roughly 60% upside to the stock's current perch at...
4/12/2019 10:13 AM
Shares of Collegium Pharmaceutical Inc (NASDAQ:COLL) are making positive moves this morning, just after landing a "buy" rating and $29 price target out of Janney Montgomery. This type of bull note is ...
6/12/2018 1:32 PM
The shares of healthcare concerns Collegium Pharmaceutical Inc (NASDAQ:COLL) and Stemline Therapeutics Inc (NASDAQ:STML) are higher today, thanks to some upbeat analyst attention. Specifically, Ca...
12/5/2017 2:33 PM
U.S. stocks are slightly higher this afternoon. Among the names making big moves are homebuilder Toll Brothers Inc (NYSE:TOL), biotech Revance Therapeutics Inc (NASDAQ:RVNC), and pharma stock Colleg...
12/5/2017 9:24 AM
Shares of Depomed Inc (NASDAQ:DEPO) are almost 12% higher in electronic trading, after the biotech said it is licensing the sales rights to its opioid pain drugs, Nucynta IR and Nucynta ER, to Colle...